The SEA pharmaceutical manufacturing market is projected to grow at a CAGR of 8%, from 2025 to 2034, driven by rising demand for generics, biologics, vaccines, and OTC products. Key trends include adoption of continuous manufacturing processes, focus on therapeutic areas like oncology, anti-diabetes, and anti-infective...Read more